Anticoagulants Market Continued to be driven by Aging Population and Rising Prevalence of Coagulation Disorders: Ken Research

Anticoagulants are class of drug used for prevention of blood clots. These substances are majorly available in leeches and blood-sucking insects. These drugs have found major application in treatment of thrombotic disorders and as supporting drug during dialysis. The drug is applied on test tubes, transfusion bags, and renal dialysis equipment for proper functioning. Though the drug class results in various side effects; anticoagulants play an important role in treatment of atrial fibrillation, coronary artery disease, deep vein thrombosis, ischemic stroke, myocardial infraction and pulmonary embolism.

Global anticoagulants market is broadly divided by type into six segments including Heparin, Warfarin, Noval Oral Anticoagulants, Vitamin K Antogonists, Direct Thrombosis Inhibitors, and others. The market is also segmented on the basis of route of administration into oral and injections. Various global pharmaceutical giants including Pfizer, Sanofi, GSK, and Baxter provide anticoagulants in their portfolio for prevention of blood clots.

Aging population and rising prevalence of coagulation disorders are the major factors which are expected to drive the anticoagulants market during future. However, unawareness about the disease especially in emerging and undeveloped economies of Asia, Latin America and Africa results in large number of undiagnosed cases of coagulation disorders, hence restraining the market.

Tentative Scope- Global Anticoagulants Market

Executive Summary
Research Methodology
Global Anticoagulants Market
- By Revenue, 2010-2015
Global Anticoagulants Market Segmentation, 2015
- By Type
  - Heparin
    - Unfractionated
    - Low Molecular Weight
    - Ultra Low Molecular Weight
  - Noval Oral Anticoagulants (NOACs)
    - Rivaroxaban
    - Apixaban
    - Dabigatran Etexilate
    - Edoxaban
  - Vitamin K Antagonists (VKA)
  - Injectable Direct Inhibitors
- By Route of Administration
  - Oral
  - Injectables
    - Intravenous Route
    - Subcutaneous Route
  - By Regions
    - North America
    - Europe
    - Asia Pacific
    - Rest of the World

Snapshot on North America Anticoagulants Market
- Market by Revenue, 2010 – 2015
- Market Segmentation
  - By Type(Heparin, VKA, NOACs, and Injectable Direct Inhibitors)
  - By Countries (US and Canada)
- Import and Export Scenario
Snapshot on Europe Anticoagulants Market
- Market by Revenue, 2010 – 2015
- Market Segmentation
  - By Type(Heparin, VKA, NOACs, and Injectable Direct Inhibitors)
  - By Countries (France, Germany, Italy, Spain, UK, and Rest of the Europe)*
- Import and Export Scenario
Snapshot on Asia Pacific Anticoagulants Market
- Market by Revenue, 2010 – 2015
- Market Segmentation
  - By Type(Heparin, VKA, NOACs, and Injectable Direct Inhibitors)
  - By Countries (China, India, Japan, Australia, and Rest of Asia Pacific)*
- Import and Export Scenario
Snapshot on Patented Anticoagulants Drugs
Trends and Developments in Global Anticoagulants Market
Regulatory Framework for Global Anticoagulants Market*
Porter’s Five Forces Analysis for Global Anticoagulants Market
Market Share of Players in global Global Anticoagulants Market (Sanofi, Aspen, Pfizer, Leo Pharma, Novartis and Others)*
Competitive Landscape for Major Players in Global Anticoagulants Market (Cover Parameters such as company overview, USP, Product Portfolio, Anticoagulants sales revenues*, margins*, number of employees*, business strategies, and key personnel)
- Sanofi
- Pfizer
- Leo Pharma
- GlaxoSmithKline
- Bristol Myers Squibb
- Teva Pharmaceutical Industries
- Baxter Healthcare Corp.
- Others
Anticoagulants Market Future Outlook and Projections
- By Revenues, 2016- 2020
- By Segments, 2016-2020
- Pipeline Analysis of Anticoagulants
Analyst Recommendations
Macroeconomic Factors affecting Global Anticoagulants Market